21
|
|
|
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma |
14-3-3GAMMA, DEE56, EIEE56, PPP1R170 |
Anxiety disorder, Attention deficit hyperactivity disorder, Autism, Cerebral atrophy, Developmental delay, Developmental regression, Dwarfism, Dyskinetic syndrome, Epileptic encephalopathy, Gastroesophageal reflux disease, Hypodontia, Mental retardation, Microcephaly, Non-specifi epileptic encephalopathy, Nystagmus, Optic atrophy, Ptosis, Schizophrenia, Scoliosis, Status epilepticusView all (5 more) |
22
|
|
|
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta |
YWHA1 |
|
23
|
|
|
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta |
14-3-3-zeta, HEL-S-3, HEL-S-93, HEL4, KCIP-1, POPCHAS, YWHAD |
|
24
|
|
|
YEATS domain containing 4 |
4930573H17Rik, B230215M10Rik, GAS41, NUBI-1, YAF9 |
|
25
|
|
|
Tyrosyl-tRNA synthetase 1 |
CMTDIC, IMNEPD2, TYRRS, YARS, YRS, YTS |
|
26
|
|
|
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta pseudogene 5 |
- |
|